borderline significantp=0.06
Following booster vaccination, we found a borderline significant (p=0.06) increase in anti-spike granzyme B responses, in particular anti-S1, in infection-naïve participants (S1 – M3 versus M6) ( Figure 3A ).
Following booster vaccination, we found a borderline significant (p=0.06) increase in anti-spike granzyme B responses, in particular anti-S1, in infection-naïve participants (S1 – M3 versus M6) ( Figure 3A ).